Personal information

Verified email addresses

Verified email domains

Activities

Works (44)

Relevance of Positive Surgical Margins in Localized Renal Cell Carcinoma After Surgical Resection: Predictive Factors and Survival Implications

Clinical Genitourinary Cancer
2024-08 | Journal article
Contributors: Luisa Egen; Allison Quan; Luise Ingvelde Monika Gottstein; Caelan Max Haney; Margarete Teresa Walach; Julia Mühlbauer; Thomas Stefan Worst; Maurice Stephan Michel; Karl-Friedrich Kowalewski
Source: check_circle
Crossref

Optimized workflow of EV enrichment from human plasma samples for downstream mass spectrometry analysis

Discover Oncology
2024-08-27 | Journal article
Contributors: Patrick Erwied; Yi Gu; Lena Simon; Martin Schneider; Dominic Helm; Maurice Stefan Michel; Philipp Nuhn; Katja Nitschke; Thomas Stefan Worst
Source: check_circle
Crossref

Contemporary Outcomes after Transurethral Procedures for Bladder Neck Contracture Following Endoscopic Treatment of Benign Prostatic Hyperplasia

Journal of Clinical Medicine
2021-06-29 | Journal article
Contributors: Clemens Rosenbaum; Malte Vetterlein; Margit Fisch; Philipp Reiss; Thomas Worst; Jennifer Kranz; Joachim Steffens; Luis Kluth; Daniel Pfalzgraf
Source: check_circle
Crossref

Treatment decision satisfaction and regret after focal HIFU for localized prostate cancer

World Journal of Urology
2021-04-12 | Journal article
Contributors: Niklas Westhoff; Ramona Ernst; Karl Friedrich Kowalewski; Laura Schmidt; Thomas Stefan Worst; Maurice Stephan Michel; Jost von Hardenberg
Source: check_circle
Crossref

Factors to improve academic success of scientifically active physicians: A research on research study.

Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen
2021-04-03 | Journal article
Source: Self-asserted source
Thomas Worst

Peritoneal flap for lymphocele prophylaxis following robotic-assisted laparoscopic radical prostatectomy with pelvic lymph node dissection: study protocol and trial update for the randomized controlled PELYCAN study.

Trials
2021-03-29 | Journal article
Source: Self-asserted source
Thomas Worst

Deep learning approach to predict lymph node metastasis directly from primary tumor histology in prostate cancer.

BJU international
2021-03-11 | Journal article
Source: Self-asserted source
Thomas Worst

[Avelumab after platinum-based chemotherapy].

Der Urologe. Ausg. A
2021-03-08 | Journal article
Source: Self-asserted source
Thomas Worst

Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer.

Journal of experimental & clinical cancer research : CR
2020-12-17 | Journal article
Source: Self-asserted source
Thomas Worst

Subtype specific expression and survival prediction of pivotal lncRNAs in muscle invasive bladder cancer.

Scientific reports
2020-11-24 | Journal article
Source: Self-asserted source
Thomas Worst

The comprehensive complication index (CCI): proposal of a new reporting standard for complications in major urological surgery.

World journal of urology
2020-08-19 | Journal article
Source: Self-asserted source
Thomas Worst

The Impact of Small Extracellular Vesicles on Lymphoblast Trafficking across the Blood-Cerebrospinal Fluid Barrier In Vitro.

International journal of molecular sciences
2020-07-31 | Journal article
Source: Self-asserted source
Thomas Worst

Phosphodiesterase <i>SMPDL3B</i> Gene Expression as Independent Outcome Prediction Marker in Localized Prostate Cancer.

International journal of molecular sciences
2020-06-19 | Journal article
Source: Self-asserted source
Thomas Worst

[Urological research in Germany : A retrospective, longitudinal observational study].

Der Urologe. Ausg. A
2020-04-28 | Journal article
Source: Self-asserted source
Thomas Worst
grade
Preferred source (of 2)‎

FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy.

Journal of clinical medicine
2020-04-02 | Journal article
Source: Self-asserted source
Thomas Worst

Vesico-urethral anastomotic stenosis following radical prostatectomy: a multi-institutional outcome analysis with a focus on endoscopic approach, surgical sequence, and the impact of radiation therapy.

World journal of urology
2020-03-31 | Journal article
Source: Self-asserted source
Thomas Worst

miR-10a-5p and miR-29b-3p as Extracellular Vesicle-Associated Prostate Cancer Detection Markers

Cancers
2019-12-21 | Journal article
Contributors: Thomas Stefan Worst; Christopher Previti; Katja Nitschke; Nicolle Diessl; Julia Christina Gross; Lena Hoffmann; Lisa Frey; Vanessa Thomas; Christoph Kahlert; Karen Bieback et al.
Source: check_circle
Crossref

ANLN and TLE2 in Muscle Invasive Bladder Cancer: A Functional and Clinical Evaluation Based on In Silico and In Vitro Data

Cancers
2019-11-21 | Journal article
Contributors: Sheng Wu; Katja Nitschke; Jakob Heinkele; Cleo-Aron Weis; Thomas Stefan Worst; Markus Eckstein; Stefan Porubsky; Philipp Erben
Source: check_circle
Crossref

The Tumor Immune Microenvironment Drives a Prognostic Relevance That Correlates with Bladder Cancer Subtypes.

Cancer immunology research
2019-04-15 | Journal article
Source: Self-asserted source
Thomas Worst

Clinical relevance of gene expression in localized and metastatic prostate cancer exemplified by FABP5.

World journal of urology
2019-01-30 | Journal article
Source: Self-asserted source
Thomas Worst

Programmed Death Ligand 1 (PD-L1) Status and Tumor-Infiltrating Lymphocytes in Hot Spots of Primary and Liver Metastases in Prostate Cancer With Neuroendocrine Differentiation.

Clinical genitourinary cancer
2018-12-21 | Journal article
Source: Self-asserted source
Thomas Worst

Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab.

European journal of cancer (Oxford, England : 1990)
2018-12-05 | Journal article
Source: Self-asserted source
Thomas Worst

CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making.

Scientific reports
2018-09-26 | Journal article
Source: Self-asserted source
Thomas Worst

Cell-Free DNA and Neuromediators in Detecting Aggressive Variant Prostate Cancer.

Oncology research and treatment
2018-09-10 | Journal article
Source: Self-asserted source
Thomas Worst

FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer.

BJU international
2018-09-09 | Journal article
Source: Self-asserted source
Thomas Worst

FOXM1 predicts disease progression in non-muscle invasive bladder cancer.

Journal of cancer research and clinical oncology
2018-06-29 | Journal article
Source: Self-asserted source
Thomas Worst

Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screening.

Oncotarget
2018-05-25 | Journal article
Source: Self-asserted source
Thomas Worst

Economy of Standards: European Association of Urology Guideline Changes Influence Treatment Costs in Stage I Testicular Cancer Patients.

Urologia internationalis
2018-03-07 | Journal article
Source: Self-asserted source
Thomas Worst

Prognostic Value of Molecular Breast Cancer Subtypes based on Her2, ESR1, PGR and Ki67 mRNA-Expression in Muscle Invasive Bladder Cancer.

Translational oncology
2018-02-23 | Journal article
Source: Self-asserted source
Thomas Worst

High CDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder Carcinoma.

Clinical genitourinary cancer
2018-02-02 | Journal article
Source: Self-asserted source
Thomas Worst

High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients.

Cancer immunology, immunotherapy : CII
2017-11-17 | Journal article
Source: Self-asserted source
Thomas Worst

Impact of Altered WNT2B Expression on Bladder Wall Fibroblasts: Implications for Apoptosis Regulation in the Stroma of the Lower Urinary Tract.

Urologia internationalis
2017-10-31 | Journal article
Source: Self-asserted source
Thomas Worst

Neutral sphingomyelinases control extracellular vesicles budding from the plasma membrane.

Journal of extracellular vesicles
2017-09-26 | Journal article
Source: Self-asserted source
Thomas Worst

The EEF1A2 gene expression as risk predictor in localized prostate cancer.

BMC urology
2017-09-18 | Journal article
Source: Self-asserted source
Thomas Worst

Tumor-derived exosomes modulate PD-L1 expression in monocytes

Science Immunology
2017-07-21 | Journal article
Contributors: Franziska Haderk; Ralph Schulz; Murat Iskar; Laura Llaó Cid; Thomas Worst; Karolin V. Willmund; Angela Schulz; Uwe Warnken; Jana Seiler; Axel Benner et al.
Source: check_circle
Crossref

Oncologic Response and Hospitalization Rate of Patients Receiving Cabazitaxel in the Fourth-Line and Beyond in Castration-Resistant Prostate Cancer: Analysis of a Retrospective Cohort and a Structured Literature Review.

Urologia internationalis
2017-07-13 | Journal article
Source: Self-asserted source
Thomas Worst

FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypes.

Oncotarget
2017-07-01 | Journal article
Source: Self-asserted source
Thomas Worst

Database-augmented Mass Spectrometry Analysis of Exosomes Identifies Claudin 3 as a Putative Prostate Cancer Biomarker

Molecular & Cellular Proteomics
2017-06 | Journal article
Contributors: Thomas Stefan Worst; Jost von Hardenberg; Julia Christina Gross; Philipp Erben; Martina Schnölzer; Ingrid Hausser; Peter Bugert; Maurice Stephan Michel; Michael Boutros
Source: check_circle
Crossref

Novel insights into a reputably irreversible process: combined mRNA and miRNA profiling of tissue from vesicourethral anastomotic stenosis after radical prostatectomy.

World journal of urology
2017-06-20 | Journal article
Source: Self-asserted source
Thomas Worst

RAB27A, RAB27B and VPS36 are downregulated in advanced prostate cancer and show functional relevance in prostate cancer cells

International Journal of Oncology
2017-02-10 | Journal article
Contributors: Thomas Worst; Yannic Meyer; Maria Gottschalt; Cleo-Aron Weis; Jost von Hardenberg; Christine Frank; Annette Steidler; Maurice Michel; Philipp Erben
Source: check_circle
Crossref

[Modern networks : Topics in the working group "Bladder cancer research" of the GeSRU Academics].

Der Urologe. Ausg. A
2017-02-01 | Journal article
Source: Self-asserted source
Thomas Worst

Cisplatin-Based Chemotherapy for Testicular Germ Cell Tumors: Complication Rates of Peripheral versus Central Venous Administration.

Urologia internationalis
2015-12-18 | Journal article
Source: Self-asserted source
Thomas Worst

IL1RN and KRT13 Expression in Bladder Cancer: Association with Pathologic Characteristics and Smoking Status.

Advances in urology
2014-07-08 | Journal article
Source: Self-asserted source
Thomas Worst

Factors influencing local tumor control in patients with neoplastic pulmonary nodules treated with microwave ablation: a risk-factor analysis.

AJR. American journal of roentgenology
2013-03-01 | Journal article
Source: Self-asserted source
Thomas Worst

Peer review (4 reviews for 4 publications/grants)

Review activity for Cancers. (1)
Review activity for Der Urologe. (1)
Review activity for European urology oncology. (1)
Review activity for PLoS medicine. (1)